Triastek offers 3D printing drug development and equipment for pharmaceutical clients from its base in Nanjing, China.
Based in Nanjing, China and established in 2015, Triastek (Nanjing) Pharmaceutical Technology Co., Ltd. is a 3D printing pharmaceutical company that provides drug development services and equipment. Its clients include Lilly, Bollinger Ingelheim, Merck and Siemens, and its products reach China, the United States, Europe, Canada and Australia. The company is at Series B stage and plans to use its latest funding for a Shanghai R&D and production center and its oral peptide pipeline.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in